:ADC

Reema Kamal Tawfiq1, Guilherme Sacchi de Camargo Correia1, Shenduo Li1

  • 1Division of Hematology and Oncology, Department of Internal Medicine, Mayo Clinic Florida, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA.

PubMed
概括

抗体-药物联合体 (ADC) 通过向瘤抗原,提供精确的肺癌治疗. 最近的试验显示了高级非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的有希望的结果.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K